Drugs And Receptors (8) Flashcards

0
Q

What’s the most common drug target?

A
  • Proteins

- GPCRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

How do drugs exert their effects?

A
  • By binding to a target.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the equation for molarity?

A
  • Molarity= g/L / MWt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many atoms are thee in a mole?

A
  • 6x10^23
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drug action on a receptor is dictated how?

A
  • Affinity and intrinsic efficacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is binding governed?

A
  • Association and dissociation

- Affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The activation of a drug and receptor is governed how?

A
  • Intrinsic efficacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do antagonists work in respect to affinity and intrinsic efficacy?

A
  • Have affinity only
  • No intrinsic efficacy
  • Blocks effects of agonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can drug-receptor interactions by binding be measured?

A
  • Via binding of radioactively labelled ligand to cells/membranes prepared from cells.
  • Low ligand conc = low binding
  • High ligand conc = high binding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Kd?

A
  • Dissociation constant
  • Measure of affinity
  • Concentration of ligand required to occupy 50% of the available receptors
  • Lower Kd = higher affinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is B max?

A
  • Max binding capacity - gives information about receptor number
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are examples of responses from drugs?

A
  • Change in signalling pathway

- Change in cell/tissue behaviour (e.g. Conc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is meant by EC50, what is it a measure of and what is it dependent on?

A
  • Effective concentration giving 50% of maximal response
  • Measure of potency
  • Affinity+efficacy=potency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is meant by concentration?

A
  • Known concentration of drug at site of action e.g. Cells and tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is meant by dose?

A
  • Concentration at site of action unknown (don’t know how body will react)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the characteristics of drugs that need to be taken into account in a clinical setting?

A
  • Affinity
  • Efficacy
  • Selectivity (off target effects?)
  • Drug metabolism/pharmacokinetics (how body deals with it)
  • Physicochemical properties (solubility/pH/stability/crystallinity)
16
Q

Why may selectivity be a problem?

A
  • If isn’t selective then will have effects on other receptors
  • e.g adrenaline on B adrenoceptors, useful for asthma but may also increase heart rate.
17
Q

What is selectivity based on?

A
  • Affinity
18
Q

In some cases <100% occupancy leads to 100% response why is this?

A
  • Spare receptors
19
Q

Why may spare receptors exist?

A
  • Amplification in signal transduction pathway response limited by post-receptor event.
20
Q

What do spare receptors allow for in terms of sensitivity?

A
  • Increases

- Allows responses at low concentrations of agonist

21
Q

A change in receptor number can lead to what?

A
  • Change in agonist potency (max response)

- E.g. 10,000 is full response. If only have 5000 receptors means can’t get full response

22
Q

How does tolerance to drugs arise?

A
  • Receptor number decreases when there’s a high activity

- Too high=no receptors available.

23
Q

When is buprenorphrine used and why?

A
  • Adequate pain relief but no respiratory problems

- Higher affinity but lower efficacy than morphine

24
Q

What role can a partial agonist act as?

A
  • Act as an antagonist to a full agonist

- Has a higher affinity but doesn’t turn on receptor as well

25
Q

What are partial agonists dependent on?

A
  • Compound and systemic
  • Increase receptor number can change a partial agonist into a full agonist, still has a low intrinsic efficacy but there are sufficient receptors to contribute to a full response
26
Q

What are the types antagonists?

A
  • Reversible/irreversible competitive antagonism

- Non-competitive antagonism (allosteric/post-receptor)

27
Q

Describe what reversible competitive antagonism is.

A
  • Competitive inhibition
  • Relies on dynamic eqm between ligands and receptors
  • As antagonist concentration concentration increase response decreases
28
Q

What is irreversible competitive antagonism?

A
  • When agonists slowly dissociate or not at all
  • With more time or antagonist concentration more receptors are blocked by antagonist. Non-surmountable
  • At higher conc suppresses max response
29
Q

What effect does irreversible competitive antagonist have on an agonist - conc response curve?

A
  • Parallel shift to the right as spare receptors filled by antagonist
30
Q

What is non-competitive antagonism?

A
  • No competition for binding site but affects orthosteric affinity and or efficacy
  • Non competitive inhibition